SavedAdd your journal

Journals / Türk Pediatri Arşivi / 2020 / Cilt: 55 - Sayı: 3

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity

Obez çocuklarda lipid metabolizması ile non-alkolik yağlı karaciğer hastalığı ilişkisi

Birgül KIREL
Gonca KILIÇ YILDIRIM
İlhan HAZER
Hilmi Onur KABUKÇU
Murat YAĞCI
Zeynep ERTÜRK
Pages
263–269
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All lipid and lipoproteinlevels were defined as hypo-, normo- and hyperlipidemic in comparisonwith the reference values according to age and sex.Results: The frequency of non-alcoholic fatty liver disease was 44.5%in the entire study group and was higher in males (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Obesity, insulin resistance, and hyperlipidemia have been shownas risk factors for non-alcoholic fatty liver disease.
📊
Key Findings & Data:In this study, the association between lipid and lipoprotein metabolism abnormalities andthe presence of non-alcoholic fatty liver disease was investigated in patients with obesity.Material and Methods: In this study, the clinical, laboratory and imagingfindings of 357 children and adolescent patients (199 girls and 158 boys)aged 2–18 years who were diagnosed as having obesity between 2013and 2018 were retrospectively analyzed.
💡
Conclusion & Impact:All lipid and lipoproteinlevels were defined as hypo-, normo- and hyperlipidemic in comparisonwith the reference values according to age and sex.Results: The frequency of non-alcoholic fatty liver disease was 44.5%in the entire study group and was higher in males (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Obesity, insulin resistance, and hyperlipidemia have been shownas risk factors for non-alcoholic fatty liver disease. In this study, the association between lipid and lipoprotein metabolism abnormalities andthe presence of non-alcoholic fatty liver disease was investigated in patients with obesity.Material and Methods: In this study, the clinical, laboratory and imagingfindings of 357 children and adolescent patients (199 girls and 158 boys)aged 2–18 years who were diagnosed as having obesity between 2013and 2018 were retrospectively analyzed. The clinical and laboratory features of the patients who were diagnosed as having non-alcoholic fattyliver disease using ultrasonography were compared with patients whodid not have non-alcoholic fatty liver disease. All lipid and lipoproteinlevels were defined as hypo-, normo- and hyperlipidemic in comparisonwith the reference values according to age and sex.Results: The frequency of non-alcoholic fatty liver disease was 44.5%in the entire study group and was higher in males (p

Özet

Amaç: Obezite, insülin direnci ve hiperlipidemi non-alkolik yağlı karaciğer hastalığı risk etmenleri olarak gösterilmektedir. Bu çalışmada obezite tanılı hastalarda lipid ve lipoprotein metabolizması anormallikleri ile non-alkolik yağlı karaciğer hastalığı varlığı arasındaki ilişkili araştırılmıştır.Gereç ve Yöntemler: Bu çalışmada; 2013–2018 yılları arasında obezite tanısı alan, yaşları 2–18 yıl arasında değişen 357 çocuk ve ergen hastanın (199 kız, 158 erkek) klinik, laboratuvar ve görünteleme bulguları geriye dönük olarak incelendi. Ultrasonografi ile non-alkolik yağlı karaciğer hastalığı saptanan hastaların klinik ve laboratuvar özellikleri non-alkolik yağlı karaciğer hastalığı olmayan hastalar ile karşılaştırıldı. Tüm lipid ve lipoproteinler kendi içlerinde yaşa ve cinsiyete göre referans değerleri ile karşılaştırılarak; hipo-, normo- ve hiperlipidemik olarak kaydedildi.Bulgular: Tüm çalışma grubunda non-alkolik yağlı karaciğer hastalığı görülme sıklığı %44,5 idi ve erkeklerde sıklık daha yüksekti (p

🔖

Cite This Article

KIREL, B., YILDIRIM, G. K., HAZER, İ., KABUKÇU, H. O., YAĞCI, M., ERTÜRK, Z. (2022). The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity. Türk Pediatri Arşivi, Cilt: 55 - Sayı: 3, 263–269. https://ajindex.com/articles/640967

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Shah J, Okubote T, Alkhouri N. Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease. Gastroenterol Hepatol (N Y) 2018; 14: 407–14.
  2. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328–57.
  3. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58: 1538–44.
  4. Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS One 2015; 10: e0140908. Gokce S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The relationship between pediatric non-alchololic fatty liver disease and cardiovasculer risk factors and increased risk of atherosclerosşs in obese children. Pediatr Cardiol 2013; 34: 308–15.
  5. Yıldız I, Erol OB, Toprak S, et al. Role of vitamin D in children with hepatosteatosis. J Pediat Gastr Nutr 2014; 59: 106–11.
  6. Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging 2013; 37: 504–8. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128: S213–56. Iqbal U, Perumpail BJ, John N, et al. Judicious Use of Lipid Lowering Agents in the Management of NAFLD. Diseases 2018; 6: 87. Bamba V. Update on screening, etiology, and treatment of dyslipidemia in children. J Clin Endocrinol Metab 2014; 99: 3093–02.
  7. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979–87. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol 2014; 25: 161–8. Muñoz Torres M, Cano Romera A, Domínguez S, Cano Parra MD, Lobón JA, Escobar Jiménez F. Familial hypobetalipoproteinemia: description of a heterozygous form with important biochemical alterations. [Article in Span-ish]. Rev Clin Esp 1991; 188: 81–2.
  8. Wishingrad M, Paaso B